Kyntra Bio Inc (KYNB) Price Prediction & ForecastKYNBKyntra Bio Inc

Alphio's KYNB stock price prediction model matches the current Kyntra Bio Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.04 (+0.28%). The 1-week path is $7.95 (-0.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Kyntra Bio Inc is a good buy right now due to its recent turnaround in net income, reporting $12 million in Q2 2026, which translates to $2.96 per share, a significant improvement from a net loss of $13.7 million in the same period last year. Additionally, the stock has shown a strong 5-day change of +6.65%, indicating positive momentum. However, investors should be cautious of the high operating costs, which reached $16.1 million in Q2 2026, as this could pressure profitability moving forward.

Kyntra Bio Inc (KYNB) last closed at $8.02, gaining +0.25%. These facts feed the 1-day and 1-week KYNB price prediction above.